| Date | Title | Description |
| 28.08.2026 | Adaptyv Secures $40M: Automated AI Lab Reshapes Drug Discovery | Adaptyv secures $40 million in Series A funding. This investment builds an automated AI lab. It tackles a critical bottleneck in drug discovery. AI now designs thousands of protein molecules quickly. Traditional labs cannot test them at thi... |
| 27.08.2026 | Adaptyv Raises $40 Million To Build the Automated AI Lab for Agentic Biology | AI can now design thousands of protein molecules in an afternoon. But it’s yet to find a way to determine if they actually work. Most labs were built to test 20 designs, not thousands of them.
For this reason, Adaptyv raises $40 million to ... |
| 27.08.2026 | Adaptyv Raises $40 Million Series A As Automated Biology Lab Throughput Grows More Than 5x | Adaptyv has raised $40 million in Series A funding to expand its automated laboratory infrastructure for agentic biology. Highland Europe led the round, with existing investors ACE Ventures, byFounders and Y Combinator increasing their inve... |
| 26.08.2026 | Adaptyv raises $40M to build automated lab for agentic biology |
Adaptyv Biosystems has developed an automated wet lab for rapid experimental validation of newly designed proteins, while drastically reducing the costs per protein. Powered by artificial intelligence, this full-stack platform makes it eas... |
| 12.08.2026 | Reed Jobs says Silicon Valley’s 'energy' has moved to San Francisco thanks to post-pandemic office prices | Steve Jobs' son thinks San Francisco's pandemic-era real estate slump helped shift Silicon Valley's center of gravity up north.
Reed Jobs said on the Sabrina Halper Show that Palo Alto and the South Bay were "where all the juice was&qu... |
| 23.07.2026 | Cheiron Scores $8M Seed Round |
LOS ALTOS, CA, Cheiron, the operating system for drug programs, announced an $8 million seed round led by Menlo Ventures.
>> Click here for more funding data on Cheiron
>> To export Cheiron funding data to PDF and Excel, click ... |
| 21.07.2026 | Chai Discovery Bags $400 Million |
SAN FRANCISCO, CA, Chai Discovery has announced new funding to accelerate its work: $400 million at a $3.8 billion valuation.
>> Click here for more funding data on Chai Discovery
>> To export Chai Discovery funding data to PDF... |
| 18.07.2026 | Chai Discovery Secures $400M, Propelling AI-Driven Molecular Design | Chai Discovery secured a $400 million Series C funding round. This elevates its valuation to $3.8 billion. The capital injection accelerates its AI-driven molecular design platform. Chai transforms drug discovery, shifting from trial-and-er... |
| 14.07.2026 | Prosperity Partners Receives Investment From Lightyear Capital | Prosperity Partners, a Chicago, IL-based tax, client accounting, and transaction support services business, is receiving a majority growth investment from Lightyear Capital.
Unity Partners, who invested in Prosperity in April of 2023, will ... |
| 14.07.2026 | Chai Discovery Raises $400M in Series C Funding | Chai Discovery, a San Francisco, CA-based company engineering AI models to discover new molecules, raised $400M in Series C funding.
The round, which valued the company at $3.8B, was led by Index Ventures alongside Kleiner Perkins, Sequoia ... |
| 14.07.2026 | Chai Discovery Raises $400M to Accelerate AI-Driven Molecular Design Platform | What You Should Know
Structural biology and AI drug design pioneer Chai Discovery has announced a $400M Series C funding round, valuing the company at $3.8 billion just two years after its 2024 founding.
The heavily oversubscribed round was... |
| 14.07.2026 | Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma | Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in new funding, nearly tripling its valuation to $3.8 billion.
Ind... |
| 14.07.2026 | Chai Discovery Raises $400 Million Series C To Advance AI-Driven Molecular Design | Chai Discovery announced a $400 million Series C financing to accelerate the development and deployment of its AI-driven molecular design platform. The round valued Chai Discovery at $3.8 billion. It was led by Index Ventures alongside Klei... |
| 14.07.2026 | Venture capital & startup funding roundup, July 14, 2026: Blackstone, General Catalyst, Index Ventures, Kleiner Perkins, Lightspeed, & Sequoia | It’s Tuesday, July 14, 2026, and the flow of capital today underscores familiar but intensifying trends: governments and venture firms are doubling down on AI infrastructure and sovereignty, as well as defense and related automation. In the... |
| 24.05.2026 | Modal Labs Valued at $4.65 Billion as AI Compute Demands Soar | Modal Labs secured $355 million in Series C funding. Its valuation soared to $4.65 billion. The AI-native cloud compute platform addresses critical industry challenges. It tackles the explosive growth of AI coding. It also confronts the inc... |
| 22.05.2026 | Modal Raises $355M in Series C Funding at Post-Money Valuation of $4.65 Billion | Modal, a New York City-based developer of an AI-native cloud compute and serverless container platform, raised $355m in Series C funding at a post-money valuation of $4.65 billion.
The round was led by General Catalyst and Redpoint, with pa... |
| 12.02.2026 | Inside Wealth Family Office 15: Most active investment firms of the ultra-wealthy | CNBC releases its inaugural Inside Wealth Family Office 15 list, ranking the most active large U.S. family offices by disclosed deal activity.
Eric Schmidt’s family office, Hillspire, made 15 investments in 2025, most of them in artificial ... |
| 29.01.2026 | CB Insights Report: Digital Health Funding Hits $22.3B as 14 New Unicorns Emerge | What You Should Know
The Rebound: According to the new State of Digital Health 2025 report from CB Insights, digital health funding rose 19% YoY to $22.3B in 2025, driven by fewer, larger checks—average deal size jumped 29% to $20.3M.
The C... |
| 09.01.2026 | Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics | What You Should Know
– Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
– The partnership includes the development of an exclusive, purpose-... |
| 02.01.2026 | Куда столько миллионов? За какие идеи стартапы получали инвестиции в 2025 году | 2025 год стал звездным для юных и амбициозных компаний. В стартапы, созданные буквально парочкой энтузиастов, вкладывались десятки и даже сотни миллионов долларов. Неудивительно, что в гонке за финансирование тысячи компаний пытаются выдели... |
| 23.12.2025 | Chai Discovery: $130 Million Series B At $1.3 Billion Valuation Raised To Advance AI-Driven Molecular Design | Chai Discovery, a San Francisco-based AI company focused on predicting and reprogramming biochemical molecule interactions, has raised a $130 million Series B financing round co-led by Oak HC/FT and General Catalyst, valuing the company at ... |
| 17.12.2025 | AI Propels Drug Discovery: Chai Discovery Secures $130M, Valued at $1.3B | AI biotech firm Chai Discovery secured $130M in new funding. This pushes its valuation to $1.3 billion. Its AI model, Chai-2, is a game-changer. It rapidly designs novel molecules and full-length antibodies. The model targets previously &qu... |
| 15.12.2025 | ИИ вместо пробирок: Chai Discovery привлек $130 млн на цифровой дизайн молекул | Американский биотехнологический стартап Chai Discovery, работающий в сфере разработки лекарств с использованием искусственного интеллекта и поддерживаемый OpenAI, привлек $130 млн (более 10 млрд руб.) в новом раунде финансирования. Оценка к... |
| 15.12.2025 | Chai Discovery Inks $130M Series B Funding |
SAN FRANCISCO, CA, Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, announced its $130 million Series B financing round co-led by Oak HC/FT and General Catalyst.
>> Click her... |
| 15.12.2025 | OpenAI-Backed Chai Discovery Raises $130M to Tackle “Undruggable” Targets with Generative AI | What You Should Know:
– Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
– Co-led by Oak HC/FT and General Catalyst, the funding validates Chai’s ... |
| 15.12.2025 | This Startup Backed By OpenAI and Jobs Family Is the Latest A.I. Drug Discovery Unicorn | Josh Meier, CEO of Chai Discovery, said his startup’s models are improving at a rapid rate. Courtesy Chai Discovery
Chai Discovery, a San Francisco-based startup backed by OpenAI, is the latest drug discovery company to benefit from a flurr... |
| 15.12.2025 | AI medical research startup Chai Discovery raises $130M in funding
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Chai Discovery Inc., a startup using artificial intelligence to accelerate drug development, today announced that it has closed a $130 million funding round led by Oak HC/FT and General Catalyst.
The two investment firms were joined by more... |
| 15.12.2025 | Chai Discovery Raises $130M in Series B Funding | Chai Discovery, a San Francisco, CA-based AI company that predicts and reprograms the interactions between biochemical molecules, raised $130M in Series B funding, at $1.3 Billion valuation.
The round was led by Oak HC/FT and General Cataly... |
| 21.10.2025 | AI-driven drugmakers fuel wave of cross-border deals in China | This year, cross-border deals in China’s innovative drug sector have accelerated, with artificial intelligence-driven firms emerging as key players. Syneron, Helixon, and XtalPi illustrate the trend, together closing business development (B... |
| 19.09.2025 | Adaptyv leaves the beta phase following its $8m seed round |
Epalinges-based Adaptyv Bio is on the mission to accelerate the design process for proteins, which today remains a long, very tedious, and expensive task as labs and companies lack the automation and data integration to perform repeatable,... |
| 07.08.2025 | Chai Discovery raises $70M to build molecular discovery foundation AI models
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Chai Discovery, a company that builds frontier artificial intelligence models to predict and reprogram interactions between biochemical molecules, today announced it has raised $70 million to continue its mission to accelerate how scientist... |
| 06.08.2025 | Chai Discovery Raises $70M in Series A Funding | Chai Discovery, a San Francisco, CA-based AI company that predicts and reprograms the interactions between biochemical molecules to accelerate life-changing therapeutics, raised $70m in Series A financing.
The round was led by Menlo Venture... |
| 06.08.2025 | Chai Discovery Pulls In $70M Series A Round |
SAN FRANCISCO, CA, Chai Discovery today announced its $70 million Series A financing round.
>> Click here for more funding data on Chai Discovery
>> To export Chai Discovery funding data to PDF and Excel, click here
Chai Discov... |
| 01.07.2025 | The AI Revolution in Drug Discovery: A New Era of Innovation | The landscape of drug discovery is undergoing a seismic shift. Two companies, XtalPi and Chai Discovery, are at the forefront of this transformation. They are harnessing the power of artificial intelligence (AI) to redefine how we approach ... |
| 01.07.2025 | The Future of Vaccines and Antibodies: A New Era in Medicine | In the world of medicine, innovation is the lifeblood that keeps the industry vibrant. Two recent breakthroughs showcase the power of science and technology in fighting diseases: Moderna's promising flu vaccine and Chai Discovery's revoluti... |
| 30.06.2025 | Docusign Strengthens Its Growth Ambitions in Europe With the Appointment of Stéphane Barberet as Gvp & General Manager for Emea | Docusign, the Intelligent Agreement Management company, announces the appointment of Stéphane Barberet as Group Vice President & General Manager for EMEA. By bringing aboard proven leadership with extensive enterprise SaaS experience, D... |
| 30.06.2025 | Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI | Chai Discovery, which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules, announced a breakthrough in the de novo design of antibodies. The company’s latest model, Chai-2, demonst... |
| 12.11.2024 | Northflank Secures $22.3 Million to Simplify Developer Workloads | In the fast-paced world of technology, developers often find themselves wrestling with complex infrastructure instead of focusing on what they do best: writing code. Northflank, a London-based startup, aims to change that narrative. With a ... |
| 11.11.2024 | Exclusive: Northflank scores $22.3 million to make cloud infrastructure less of a nightmare for developers | Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Northflank, a London-based cloud deployment platform, announced $22.3 million in new funding today to help compan... |
| 11.11.2024 | Northflank: Developer Workload Platform Company Secures $22.3 Million | Northflank, a developer workload platform, announced $22.3 million in new funding, including a $16 million Series A led by Bain Capital Ventures (BCV) and a $6.3 million seed led by Vertex Ventures US. Additional investors participating in ... |
| - | Chai Discovery | “Building AI foundation models to predict and reprogram the interactions between biochemical molecules, the fundamental building blocks of life. ” |
| - | Chai Discovery | “Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.” |
